An Israeli company will partner with an Australian one to help boost clinical education opportunities around medical cannabis.
The two companies, iCAN: Israel-Cannabis and Melbourne-based LeafCann have announced a joint-venture to collaborate on a range of initiatives including medicinal cannabis research, product development, and education.
The venture will be called iCAN: Australia, and, according to LeafCann Group CEO Jaroslav Boublik, the companies will “develop global clinical education initiatives to bridge the gap between public demand and practitioner education.”
Click here to read the complete article
Joe Wilson ~ Leafly.com via 420Intel.com ~
